Cargando…
Sinonasal malignancies: histopathological entities, regional involvement and long-term outcome
BACKGROUND: To assess a large patient cohort with sinonasal malignancies focusing on regional involvement, recurrence and oncological outcome. METHODS: Patients (n = 144) with malignant tumors of the nasal cavity and paranasal sinuses were treated at our tertiary referral center between 2008 and 201...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148547/ https://www.ncbi.nlm.nih.gov/pubmed/37118840 http://dx.doi.org/10.1186/s40463-023-00627-8 |
_version_ | 1785034996731346944 |
---|---|
author | Anschuetz, Lukas Hohenberger, Ralph Kaecker, Christoph Elicin, Olgun Giger, Roland Caversaccio, Marco |
author_facet | Anschuetz, Lukas Hohenberger, Ralph Kaecker, Christoph Elicin, Olgun Giger, Roland Caversaccio, Marco |
author_sort | Anschuetz, Lukas |
collection | PubMed |
description | BACKGROUND: To assess a large patient cohort with sinonasal malignancies focusing on regional involvement, recurrence and oncological outcome. METHODS: Patients (n = 144) with malignant tumors of the nasal cavity and paranasal sinuses were treated at our tertiary referral center between 2008 and 2019. A chart review on patient and tumor characteristics, treatment and long-term outcome was performed. RESULTS: Most frequent histological types were squamous cell carcinoma (SCC) (n = 74), adenocarcinoma (n = 24) and mucosal melanoma (n = 18). Primary therapy was surgery in 66% of patients (n = 95) of which 65.8% (n = 66) received adjuvant radiotherapy. Twenty patients (13.8%) were initially staged as cN + and in seven cases, pN + status was histopathologically confirmed. Fifty-six of 130 patients (43.1%) had a relapse after curative intended therapy, including nine loco-regional (6.9%) and seven isolated regional recurrences (5.4%). Twelve of these 16 patients with (loco-)regional recurrence had SCC. Adenoid cystic carcinoma (87.5%) and SCC (65.3%) showed the best long-term overall survival. CONCLUSIONS: Regional involvement and regional recurrence are scarce. Because of rarity and heterogeneity, evidence on therapeutic management is sparse resulting in the lack of clinical guidelines. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-10148547 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101485472023-04-30 Sinonasal malignancies: histopathological entities, regional involvement and long-term outcome Anschuetz, Lukas Hohenberger, Ralph Kaecker, Christoph Elicin, Olgun Giger, Roland Caversaccio, Marco J Otolaryngol Head Neck Surg Original Research Article BACKGROUND: To assess a large patient cohort with sinonasal malignancies focusing on regional involvement, recurrence and oncological outcome. METHODS: Patients (n = 144) with malignant tumors of the nasal cavity and paranasal sinuses were treated at our tertiary referral center between 2008 and 2019. A chart review on patient and tumor characteristics, treatment and long-term outcome was performed. RESULTS: Most frequent histological types were squamous cell carcinoma (SCC) (n = 74), adenocarcinoma (n = 24) and mucosal melanoma (n = 18). Primary therapy was surgery in 66% of patients (n = 95) of which 65.8% (n = 66) received adjuvant radiotherapy. Twenty patients (13.8%) were initially staged as cN + and in seven cases, pN + status was histopathologically confirmed. Fifty-six of 130 patients (43.1%) had a relapse after curative intended therapy, including nine loco-regional (6.9%) and seven isolated regional recurrences (5.4%). Twelve of these 16 patients with (loco-)regional recurrence had SCC. Adenoid cystic carcinoma (87.5%) and SCC (65.3%) showed the best long-term overall survival. CONCLUSIONS: Regional involvement and regional recurrence are scarce. Because of rarity and heterogeneity, evidence on therapeutic management is sparse resulting in the lack of clinical guidelines. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2023-04-28 /pmc/articles/PMC10148547/ /pubmed/37118840 http://dx.doi.org/10.1186/s40463-023-00627-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Original Research Article Anschuetz, Lukas Hohenberger, Ralph Kaecker, Christoph Elicin, Olgun Giger, Roland Caversaccio, Marco Sinonasal malignancies: histopathological entities, regional involvement and long-term outcome |
title | Sinonasal malignancies: histopathological entities, regional involvement and long-term outcome |
title_full | Sinonasal malignancies: histopathological entities, regional involvement and long-term outcome |
title_fullStr | Sinonasal malignancies: histopathological entities, regional involvement and long-term outcome |
title_full_unstemmed | Sinonasal malignancies: histopathological entities, regional involvement and long-term outcome |
title_short | Sinonasal malignancies: histopathological entities, regional involvement and long-term outcome |
title_sort | sinonasal malignancies: histopathological entities, regional involvement and long-term outcome |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148547/ https://www.ncbi.nlm.nih.gov/pubmed/37118840 http://dx.doi.org/10.1186/s40463-023-00627-8 |
work_keys_str_mv | AT anschuetzlukas sinonasalmalignancieshistopathologicalentitiesregionalinvolvementandlongtermoutcome AT hohenbergerralph sinonasalmalignancieshistopathologicalentitiesregionalinvolvementandlongtermoutcome AT kaeckerchristoph sinonasalmalignancieshistopathologicalentitiesregionalinvolvementandlongtermoutcome AT elicinolgun sinonasalmalignancieshistopathologicalentitiesregionalinvolvementandlongtermoutcome AT gigerroland sinonasalmalignancieshistopathologicalentitiesregionalinvolvementandlongtermoutcome AT caversacciomarco sinonasalmalignancieshistopathologicalentitiesregionalinvolvementandlongtermoutcome |